Corex stands at the intersection of two dynamic industries. On one side, you have Corex Group, a European powerhouse that manufactures paper tubes and sustainable packaging solutions for manufacturers worldwide. On the other, Corex Pharma operates as a global clinical supply and logistics partner, connecting pharmaceutical companies with patients across complex markets. Whether you're looking to source high-quality paper cores or navigate the intricate world of pharmaceutical distribution, Corex brings decades of expertise and a local-first approach to every challenge.
In 2026, supply chain sophistication matters more than ever. Companies need partners who understand both the technical specifications of their products and the regulatory landscape they operate within. Corex delivers exactly that combination, with a presence across 15 countries for its packaging division and a pharmaceutical network spanning 80+ countries. This guide walks you through what makes Corex a trusted name in two distinct but equally demanding sectors.
| Corex Division | Primary Service | Geographic Reach | Key Strength |
|---|---|---|---|
| Corex Group | Paper tubes, cores, packaging | 15 countries, 29 companies | Sustainable manufacturing, local expertise |
| Corex Pharma | Clinical supply, regulatory services | 80+ countries | Compliance, temperature-controlled distribution |
| Combined Workforce | Integrated industrial solutions | Part of VPK Group ecosystem | Vertical integration, operational synergy |
Corex operates through two interconnected divisions: a 29-company paper manufacturing and packaging network producing 300,000 tonnes annually, and a pharmaceutical logistics platform serving clinical trials and market access across 80+ countries. Both divisions prioritize compliance, sustainability, and local partnership models.
What is Corex and Which Industry Does It Serve?
Corex Group: Paper Cores, Tubes, and Packaging Solutions
Corex Group forms the packaging and industrial materials division of the larger VPK Group, a vertically integrated industrial conglomerate. The division specializes in manufacturing paper-based solutions that range from simple cardboard tubes to sophisticated edge protectors and consumer packaging applications. With approximately 1,300 employees spread across 29 facilities in 15 European countries, Corex Group produces roughly 300,000 tonnes of cardboard tubes and related products every year.
The division serves manufacturers in textiles, films, foils, paper, food, and industrial sectors. When a textile mill needs cores for its yarn production or a food brand requires custom edge protection for shipping, Corex delivers tailor-made solutions. The manufacturing process involves both spiral wound and parallel (convolute) wound tube technologies, each suited to different applications and performance requirements. By keeping production facilities close to customers across Europe, Corex reduces lead times and transportation costs while maintaining quality control over every unit shipped.
Corex Pharma: Clinical Supply and Logistics for the Pharmaceutical Industry
Corex Pharma operates as a specialized pharmaceutical logistics and supply chain partner, distinct from the packaging division but sharing the same commitment to compliance and operational excellence. This division connects pharmaceutical companies with patients by managing complex clinical trial supply chains, regulatory importation services, and temperature-controlled distribution networks. The business serves a global footprint: 80+ countries, 1,500+ active projects, and partnerships with some of the world's largest pharmaceutical organizations.
Where clinical trials demand precision, Corex Pharma delivers. The division handles everything from sourcing comparator drugs and managing clinical supply logistics to clearing customs and serving as an Importer of Record for new markets. In emerging markets and regulated jurisdictions, Corex navigates the bureaucratic and logistical maze so pharmaceutical companies can focus on development and patient outcomes. Temperature-controlled storage facilities, track-and-trace infrastructure, and regulatory expertise transform what could be a liability into a competitive advantage for its pharmaceutical clients.
How Does Corex Manufacture Spiral and Parallel Wound Paper Tubes?
Spiral Wound Tube Production Process
Spiral wound tubes represent the backbone of Corex's manufacturing portfolio. The process begins with rolls of kraft paper or other base materials being fed into specialized winding equipment. These machines wrap the paper in a continuous spiral motion around a rotating mandrel, layer upon layer, until the desired wall thickness and diameter are achieved. Each layer bonds to the next through adhesive application, creating a monolithic structure that's both strong and lightweight.
The beauty of spiral winding lies in its versatility. By adjusting the paper grade, number of wraps, adhesive type, and mandrel diameter, Corex can produce tubes ranging from lightweight packaging cores to heavy-duty industrial spools capable of supporting thousands of pounds of tension. A textile manufacturer might order spiral tubes with specific stiffness values for yarn winding, while a film converter could request tubes with precise inner diameters for film roll applications. The spiral configuration also creates a product with superior crushing strength compared to weight, which translates to lower transportation costs and reduced material waste.
Parallel Wound Tube Applications and Benefits
Parallel wound (also called convolute wound) tubes follow a different logic. Rather than spiraling continuously, the paper wraps around the mandrel in parallel layers, each perpendicular or nearly perpendicular to the previous one. This construction creates tubes with different strength characteristics: excellent radial strength and superior dimensional stability, making them ideal for applications where precision matters.
Food packaging, composite material storage, and precision mechanical applications all favor parallel wound tubes. A bakery supply company might use parallel wound tubes to package flour or sugar because the construction resists compression and maintains shape under shelf stacking. An automotive component manufacturer might choose them for protecting expensive parts during shipment. Corex produces parallel wound tubes with wall thicknesses from 3mm to 50mm and diameters up to 1,500mm, all customized to precise customer specifications and tested against international quality standards.
Quality Standards and Certifications
Manufacturing at scale requires discipline around quality. Corex holds certifications including ISO 9001 (quality management) and FSC (Forest Stewardship Council) accreditation for sustainable sourcing. Every production run undergoes testing for crushing strength, puncture resistance, moisture content, and dimensional accuracy. Products destined for food contact applications meet EU and FDA food safety regulations. Pharmaceutical-grade packaging produced by Corex Pharma meets GMP (Good Manufacturing Practice) standards and pharmaceutical-specific regulations.
The company invests continuously in R&D and equipment upgrades to maintain quality leadership. Digital monitoring systems track production parameters in real time, flagging deviations before they result in out-of-spec products. This approach reduces waste, shortens changeover times between customer orders, and ensures that every tube leaving a Corex facility meets or exceeds customer expectations. For clients operating in regulated industries like food or pharmaceuticals, this reliability translates to peace of mind and reduced auditing burden.
What Makes Corex a Leader in Sustainable Packaging Solutions?
Environmental Commitment and Sustainability Practices
Corex Group integrates sustainability into its operating model rather than treating it as an afterthought. The company sources paper from FSC-certified forests and suppliers who follow responsible harvesting practices. By using recycled fiber and virgin fiber responsibly, Corex reduces its environmental footprint while maintaining the performance characteristics that customers demand. The manufacturing process itself relies on water-based adhesives and energy-efficient winding equipment, minimizing chemical releases and energy consumption per unit produced.
The packaging division's commitment extends to helping customers reduce their own environmental impact. By manufacturing lighter-weight tubes without sacrificing strength, Corex enables customers to ship products with less packaging material. A clothing brand using Corex edge protectors ships more units per container, reducing overall transportation emissions. A paper mill using Corex cores for its products benefits from tubes that integrate seamlessly into existing recycling streams. In 2026, as regulatory pressure around packaging waste intensifies across Europe and beyond, Corex's sustainable positioning becomes a genuine competitive advantage rather than a marketing claim.
Innovation in Consumer Packaging and Edge Protectors
Beyond industrial tubes, Corex innovates in consumer-facing applications. Edge protectors (also called angle boards or corner boards) protect goods during shipping and storage by absorbing impact and distributing weight. Corex manufactures edge protectors from recycled fiber and virgin materials, offering configurations suited to everything from fragile ceramics to heavy machinery. Retailers and logistics companies appreciate the cost savings: stronger packaging that weighs less reduces freight bills and warehouse storage requirements.
Consumer packaging represents another growth area. Corex produces cardboard tubes for cosmetics, food products, and specialty items, often customizing them with printing, specialized finishes, or unique structural designs. A luxury brand might commission Corex to create a custom tube for a limited-edition product launch, benefiting from the company's design expertise and rapid prototyping capabilities. These applications demonstrate that paper-based packaging, when engineered thoughtfully, can be both sustainable and premium.
Long-Term Value Creation Through Local Expertise
Corex operates through a network of local companies in different countries rather than a single centralized manufacturing hub. This distributed model creates value in multiple ways. Proximity to customers reduces lead times and transportation costs, making Corex more responsive than distant competitors. Local management understands regional market preferences, regulatory requirements, and supply chain dynamics better than a distant corporate office could. When a customer needs to modify a specification on short notice or troubleshoot a production issue, they have direct access to experienced local engineers and managers.
This local-first approach also builds durable customer relationships. A paper mill in Spain works with the same Corex team year after year, building trust and institutional knowledge about the mill's evolving needs. That continuity drives innovation: Corex suggests improvements to tube design based on customer feedback, anticipates future volume requirements, and sometimes invests in new equipment specifically to serve a key account better. Over time, these partnerships create switching costs and loyalty that pure commodity suppliers struggle to match.
How Does Corex Support Global Pharmaceutical Distribution?
Clinical Trial Supply Chain Management
Clinical trials represent the most heavily regulated, time-sensitive segment of pharmaceutical supply chains. A drug candidate progresses through Phase 1, 2, and 3 trials, each requiring precise supply of investigational medicinal products to clinical sites distributed globally. Delays, temperature excursions, or regulatory non-compliance can derail years of development work and cost hundreds of millions of dollars.
Corex Pharma manages this complexity end-to-end. The division sources comparator drugs (reference standards used in trials), manufactures or procures investigational medicinal products, establishes temperature-controlled storage networks, and coordinates logistics to clinical sites across multiple continents. Real-time tracking ensures visibility into shipment status and temperature conditions. Cold chain management includes backup power systems, insulated packaging, and contingency protocols for unexpected disruptions. When a clinical site reports that investigational product has arrived damaged, Corex has rapid-response procedures in place: immediate replacement shipments, root-cause investigation, and corrective actions to prevent recurrence.
Regulatory and Importation Services
Every country where a pharmaceutical company wants to conduct a clinical trial requires navigating its regulatory framework. This means working with customs authorities, importing goods, obtaining permits, and sometimes appointing a local Importer of Record (IOR) to assume legal responsibility for imported medicinal products. For companies new to a market or lacking local regulatory expertise, this maze can consume months and create project delays.
Corex Pharma simplifies this process. The company's regulatory teams work in key markets across Africa, Asia, Latin America, Europe, and the Middle East. They understand local requirements, build relationships with regulatory authorities, and handle the paperwork and compliance obligations that consume time and create risk. A pharmaceutical company launching a Phase 3 trial in Nigeria can rely on Corex to serve as IOR, clear customs, coordinate with local regulators, and establish storage and distribution infrastructure, all while the company's own teams focus on enrollment and data collection. This service model compresses timelines and reduces the regulatory risk that non-compliance creates.
Temperature-Controlled Storage and Distribution Networks
Many investigational drugs, biologics, and comparator substances require storage at 2-8 degrees Celsius (refrigerated) or even minus 20 degrees Celsius (frozen). Maintaining these conditions across weeks of transport, through multiple borders and climate zones, and at multiple storage facilities demands infrastructure and vigilance. A single temperature excursion of even a few degrees can compromise product integrity and create regulatory liability.
Corex has invested in a network of temperature-controlled warehouses and distribution hubs positioned strategically across its 80+ operating countries. Climate-controlled facilities use redundant refrigeration systems, backup power generation, and continuous monitoring systems that alert staff to any deviation in real time. Transportation relies on insulated containers, phase-change materials, and temperature-logging devices that create an auditable record of conditions throughout the shipment journey. In 2026, as biologics and complex therapies become more prevalent in clinical development, this cold chain infrastructure becomes increasingly valuable. Corex's investment in temperature management transforms it from a logistics provider into a critical partner in bringing new medicines to patients safely and on schedule.
Why Choose Corex as Your Service Partner?
Global Network and Local Presence Across Multiple Countries
Scale and accessibility rarely go together, but Corex manages both. With 29 companies in the packaging division and operations spanning 80+ countries in the pharmaceutical division, Corex offers global reach. Simultaneously, each country or region maintains its own local team with deep knowledge of the market, regulatory environment, and customer base. When you partner with Corex, you're not working with a distant corporate headquarters that needs weeks to understand your situation and make decisions. You're working with local experts who know their market inside and out.
This combination unlocks practical advantages. A multinational consumer goods company using Corex for edge protectors can maintain a single point of contact for global purchasing while accessing local production and technical support in each major market. A pharmaceutical company launching clinical trials across multiple regions can rely on coordinated global strategy with tailored local execution. The network effect also means Corex can shift production between facilities if one location faces capacity constraints or supply disruptions, providing supply chain resilience that smaller suppliers cannot match.
Industry Recognition and Customer Trust
Corex operates at scale within two industries where performance failures create serious consequences. In packaging, a tube that fails under tension can halt a customer's production line and damage brand reputation if inferior products reach consumers. In pharmaceuticals, supply chain errors can delay clinical trials, frustrate patients awaiting treatments, and create regulatory liability. The fact that Corex maintains partnerships with multinational companies, major pharmaceutical organizations, and sophisticated industrial customers reflects years of reliable performance and demonstrated competence.
The company's ownership structure reinforces this credibility. Corex Group operates as part of VPK Group, a larger European industrial conglomerate with 6,400 employees across 70 plants in 20 countries. This affiliation provides financial stability, access to capital for equipment and facility improvements, and corporate governance standards that reassure enterprise customers. Similarly, Corex Pharma's operations across regulated markets and compliance with GMP standards signal commitment to quality and regulatory adherence that pharmaceutical companies require. Neither division operates as a startup or a marginal player, which translates into confidence that Corex will be available to support customers' needs today and years into the future.
Comprehensive Service Ecosystem and Compliance Standards
Corex goes beyond simply providing products or logistics services. The company builds integrated service ecosystems that address multiple customer needs simultaneously. For a pharmaceutical company, that might mean comparative drug sourcing, regulatory importation, clinical trial supply logistics, and patient access programs all coordinated by a single partner. For a manufacturing customer, it might mean custom tube design, local production, technical support, and supply chain continuity all backed by a single contract.
This integration reduces friction and improves outcomes. Instead of coordinating between multiple vendors with different quality standards and communication styles, customers work with one organization that owns the entire process. If a supply issue emerges, responsibility is clear and accountability runs deep. Corex's compliance credentials across both divisions underscore this commitment: ISO 9001, FSC certification, GMP standards, and regulatory approvals across multiple jurisdictions. In 2026, as regulations tighten around packaging waste, pharmaceutical traceability, and environmental responsibility, Corex's head start on compliance positioning provides a moat that competitors struggle to match.
Conclusion
Corex represents a rare combination: a global industrial partner with the scale and resources to serve multinational customers, paired with local expertise and responsiveness that smaller suppliers cannot replicate. Whether you're sourcing paper tubes and sustainable packaging or managing complex pharmaceutical clinical supply chains, Corex brings decades of industry experience, a network spanning multiple continents, and a commitment to compliance and customer success.
In 2026, supply chain reliability, regulatory confidence, and sustainability are no longer optional competitive advantages for most companies. They're baseline requirements. By choosing Corex as your partner, you gain access to proven expertise, integrated services, and operational infrastructure that simplify your most demanding supply chain challenges. That simplification translates to lower costs, faster timelines, and reduced risk, freeing your organization to focus on innovation and growth.